Ar­row­head adds newest fa­cil­i­ty to its Mid­west hub in RNAi drug pro­duc­tion push

Ar­row­head Phar­ma­ceu­ti­cals has pur­chased 13 acres of land in Wis­con­sin’s Verona Tech­nol­o­gy Park and will build a 140,000-square-foot drug man­u­fac­tur­ing fa­cil­i­ty.

The com­pa­ny will spend …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER